Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 26749521)

Published in J Gastroenterol Hepatol on June 01, 2016


Basile Njei1,2, Thomas R McCarty1, John W Birk3

Author Affiliations

1: Section of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
2: Investigative Medicine Program, Yale Center of Clinical Investigation, New Haven, Connecticut, USA.
3: Department of Medicine, Division of Gastroenterology and Hepatology, University of Connecticut, Farmington, Connecticut, USA.

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38

Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63

Esophageal cancer. N Engl J Med (2003) 15.23

Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol (2008) 7.94

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol (2007) 6.08

Use of SEER-Medicare data for measuring cancer surgery. Med Care (2002) 4.27

Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13

Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07

Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer (2001) 3.02

Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (1995) 2.92

Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev (2010) 2.54

Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology (2001) 2.31

Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology (1995) 2.23

Validity of death certificates for injury-related causes of death. Am J Epidemiol (1989) 2.11

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol (2007) 2.07

Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol (2007) 2.06

Treatment outcomes of resected esophageal cancer. Ann Surg (2002) 2.03

Trends in esophageal adenocarcinoma incidence and mortality. Cancer (2012) 2.03

Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer (2003) 1.99

Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer (2008) 1.85

Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg (1996) 1.74

Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol (2013) 1.65

Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol (2012) 1.61

Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer (1993) 1.57

Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology (2005) 1.56

Practice patterns for surveillance of Barrett's esophagus in the united states. Gastrointest Endosc (2000) 1.29

Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Int J Cancer (1996) 1.03

The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006). Scand J Gastroenterol (2011) 1.02

Changes in age, stage distribution, and survival of patients with esophageal adenocarcinoma over three decades in the United States. Ann Surg Oncol (2011) 0.97

National trends in esophageal surgery--are outcomes as good as we believe? J Gastrointest Surg (2009) 0.95

Curative treatment of oesophageal carcinoma: current options and future developments. Radiat Oncol (2011) 0.94

Association of esophageal adenocarcinoma with other subsequent primary cancers. J Clin Gastroenterol (2006) 0.91

Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis. Am J Clin Oncol (2009) 0.90

Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD? Gastrointest Endosc (2008) 0.86

Between-within models for survival analysis. Stat Med (2013) 0.84

Matched survival data in a co-twin control design. Lifetime Data Anal (2013) 0.80